Glucose Data Wants to Be Ambient
By IRAKLI KURTANIDZE I have lived with type 1 diabetes for more than twelve years,…
Glucose Data Wants to Be Ambient
By IRAKLI KURTANIDZE I have lived with type 1 diabetes for more than twelve years, and I check my glucose the way most people check the time: dozens of times a day, in glances that last a second or two. A continuous glucose monitor sits on my arm and produces a fresh number every few…
DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens
DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data to provide insulin dosing recommendations for people with Type 2 diabetes who need both basal insulin and fast-acting injections. The post DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens…
New Coalition Launches to Expand Direct Contracting
The Association for Direct Care launched a coalition focused on expanding direct contracting to lower healthcare costs. The post New Coalition Launches to Expand Direct Contracting appeared first on MedCity News.
CTC, Med Tech Partnership Helps FQHCs Overcome Barriers to Epic Adoption
C3’s innovative approach leverages collective purchasing power and dedicated support to enable Federally Qualified Health Centers to access advanced EHR technology
Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch
Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the cancer-driving protein KRAS G12D. This class of targeted cancer therapies includes clinical-stage assets from Revolution Medicines, BridgeBio Oncology Therapeutics, and Verastem Oncology. The post Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch appeared first on…
Task Force Recommends Massachusetts Set Primary Care Spending Target
Report also calls for development of an advanced primary care payment model
AMA, Atalan Collaborate on Physician Retention Research
Researchers will examine how physician perceptions align, or diverge, from day-to-day practice realities and identify factors associated with retention, patient access, and team performance
The pharmacy pays $1,302. The patient pays $299
By JOHN SAMARAS A US retail pharmacy pays $1,302 to acquire one month of branded Wegovy. That figure comes from the Centers for Medicare and Medicaid Services National Average Drug Acquisition Cost file, effective August 19, 2026, for the 25 mg oral tablet at 30 tablets a month. The cheapest cash price I verified on…
Why Blue Shield of California Is Doubling Down on Virtual Care
Jigar Shah, the company’s senior vice president and chief marketing and strategy officer, discusses impact of virtual care on utilization, cost and access
Beyond One-Size-Fits-All: Women, Substance Use, and the Need for Gender-Responsive Care
While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: gender meaningfully influences how substance use develops, how it is experienced, and what supports effective treatment. The post Beyond One-Size-Fits-All: Women, Substance Use, and the Need for Gender-Responsive Care appeared first on MedCity News.
